Evotec SE (EVO) Liabilities and Shareholders Equity (2019 - 2026)
Evotec SE's (EVO) quarterly Liabilities and Shareholders Equity came in at $1.9 million in Q1 2026, down 6.16% year-on-year from $2.0 million in Q1 2025, and up 96125.58% quarter-over-quarter from $1995.1 in Q4 2025.
Evotec SE (EVO) Liabilities and Shareholders Equity (2019 - 2026) Analysis & Trends
Evotec SE has disclosed Liabilities and Shareholders Equity across 8 years of filings, most recently posting $1.9 million for Q1 2026.
- Liabilities and Shareholders Equity for Q1 2026 came in at $1.9 million, down 6.16% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.0 million (down 100.0% YoY), and the FY2025 annual result was $1995.1, down 100.0% from the prior year.
- Liabilities and Shareholders Equity came in at $1.9 million for Q1 2026 at Evotec SE, up from $1995.1 in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $2452.3 billion in Q1 2022 to a low of $1995.1 in Q4 2025.
- The 5-year median for Liabilities and Shareholders Equity is $49.2 million (2022), against an average of $776.8 billion.
- Across the five-year window, Liabilities and Shareholders Equity jumped 109429290.55% in 2022 and tumbled 100.0% in 2025, its largest moves.
- Evotec SE's Liabilities and Shareholders Equity stood at $55.0 million in 2022, then fell by 21.06% to $43.4 million in 2023, then jumped by 4610.0% to $2.0 billion in 2024, then sank by 100.0% to $1995.1 in 2025, then surged by 96125.58% to $1.9 million in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $1.9 million (Q1 2026), $1995.1 (Q4 2025), and $2.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 40.04 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 15.15 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 6.71 Bn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 555.95 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 4.91 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 13.22 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 4.26 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 2.35 Bn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 2.27 Bn |
| 10 | Evotec SE | 583.10 Mn | 582.58 Mn | - | 1.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.92 Mn |
| Dec 31, 2025 | 1,995.11 |
| Sep 30, 2025 | 2.07 Mn |
| Jun 30, 2025 | 2.05 Mn |
| Mar 31, 2025 | 2.05 Mn |
| Dec 31, 2024 | 2.04 Bn |
| Sep 30, 2024 | 2,186.35 Bn |
| Mar 31, 2024 | 2,399.39 Bn |
| Dec 31, 2023 | 43.39 Mn |
| Dec 31, 2022 | 54.97 Mn |
| Sep 30, 2022 | 2,281.39 Bn |
| Mar 31, 2022 | 2,452.33 Bn |
| Dec 31, 2021 | 29.12 Mn |
| Sep 30, 2021 | 2.08 Mn |
| Dec 31, 2020 | 23.00 Mn |
| Dec 31, 2019 | 12.69 Mn |